Cameron R J, Kolbe J, Wilsher M L, Lambie N
Respiratory Services, Green Lane Hospital, Green Lane West, Auckland 3, New Zealand.
Thorax. 2000 Mar;55(3):249-51. doi: 10.1136/thorax.55.3.249.
The spectrum of nitrofurantoin lung injury continues to widen. The case histories are presented of two patients who developed lung disease associated with the use of nitrofurantoin with histological features of bronchiolitis obliterans organising pneumonia (BOOP), a rare but recognised form of drug induced injury. The two middle aged women presented with respiratory symptoms after prolonged treatment with nitrofurantoin. Both had impaired lung function and abnormal computed tomographic scans, and their condition improved when nitrofurantoin was withdrawn and corticosteroid treatment commenced. The favourable outcome in these two patients contrasts with the fatal outcome of the two other reported cases of nitrofurantoin induced BOOP. We suggest that the previous classification of nitrofurantoin induced lung injury into "acute" and "chronic" injury is an oversimplification in view of the wide variety of pathological entities that have subsequently emerged.
呋喃妥因所致肺损伤的范围在不断扩大。本文报告了两例患者的病例史,这两名患者在使用呋喃妥因后出现了肺部疾病,组织学特征为闭塞性细支气管炎伴机化性肺炎(BOOP),这是一种罕见但已被认可的药物性损伤形式。这两名中年女性在长期使用呋喃妥因治疗后出现呼吸道症状。两人均有肺功能受损及计算机断层扫描异常,停用呋喃妥因并开始使用皮质类固醇治疗后病情好转。这两名患者的良好预后与另外两例报告的呋喃妥因所致BOOP的致命结局形成对比。鉴于随后出现的多种病理实体,我们认为先前将呋喃妥因所致肺损伤分为“急性”和“慢性”损伤的分类过于简单化。